Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)
Clinical trial NCT03689114 · COMPLETED
Trial details
- NCT number
- NCT03689114
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-10
- Primary completion
- 2024-06-30
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.